1522 related articles for article (PubMed ID: 33869028)
21. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
[TBL] [Abstract][Full Text] [Related]
22. Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.
Zhang Y; Dai J; Huang W; Chen Q; Chen W; He Q; Chen F; Zhang P
Aging (Albany NY); 2021 Dec; 13(24):25980-26002. PubMed ID: 34958632
[TBL] [Abstract][Full Text] [Related]
23. Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma.
Li T; Tong H; Zhu J; Qin Z; Yin S; Sun Y; Liu X; He W
Front Med (Lausanne); 2021; 8():777507. PubMed ID: 35083240
[TBL] [Abstract][Full Text] [Related]
24. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.
Tan D; Miao D; Zhao C; Shi J; Lv Q; Xiong Z; Yang H; Zhang X
BMC Cancer; 2023 Mar; 23(1):264. PubMed ID: 36949462
[TBL] [Abstract][Full Text] [Related]
26. Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy.
Hu J; Xu L; Shou T; Chen Q
Transl Lung Cancer Res; 2019 Oct; 8(5):614-635. PubMed ID: 31737498
[TBL] [Abstract][Full Text] [Related]
27. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.
Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y
Front Genet; 2021; 12():726369. PubMed ID: 34721523
[TBL] [Abstract][Full Text] [Related]
28. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis.
Zhou L; Ye J; Wen F; Yu H
Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950
[TBL] [Abstract][Full Text] [Related]
29. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
[TBL] [Abstract][Full Text] [Related]
31. LINC01480 as a Prognostic Biomarker Associated With Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma.
Ma Y; Wu C; Deng S
Anticancer Res; 2023 Jul; 43(7):3037-3046. PubMed ID: 37351956
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
Front Oncol; 2020; 10():780. PubMed ID: 32587825
[No Abstract] [Full Text] [Related]
33. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
Jiang W; Guo Q; Wang C; Zhu Y
Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
35. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of m
Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
[TBL] [Abstract][Full Text] [Related]
37. Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model.
Xiang X; Guo Y; Chen Z; Zhang F; Qin Y
Cancer Biomark; 2023; 37(2):95-107. PubMed ID: 37248883
[TBL] [Abstract][Full Text] [Related]
38. Construction of a ceRNA Network and a Prognostic lncRNA Signature associated with Vascular Invasion in Hepatocellular Carcinoma based on Weighted Gene Co-Expression Network Analysis.
Tao H; Li J; Liu J; Yuan T; Zhang E; Liang H; Huang Z
J Cancer; 2021; 12(13):3754-3768. PubMed ID: 34093785
[No Abstract] [Full Text] [Related]
39. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.
Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F
Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642
[TBL] [Abstract][Full Text] [Related]
40. A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.
Shi D; Qu Q; Chang Q; Wang Y; Gui Y; Dong D
Oncotarget; 2017 Aug; 8(35):58699-58708. PubMed ID: 28938589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]